Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Progression of Acute Myeloid Leukemia from First Diagnosis to Chemoresistant Relapse: A Comparison of Proteomic and Phosphoproteomic Profiles
Elise Aasebø, Frode S. Berven, Randi Hovland, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1466-1466
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Proteomics: Concepts and applications in human medicine
Safa Al-Amrani, Zaaima AL-Jabri, Adhari AlZaabi, et al.
World Journal of Biological Chemistry (2021) Vol. 12, Iss. 5, pp. 57-69
Open Access | Times Cited: 197
Abnormal Expression of Mitochondrial Ribosomal Proteins and Their Encoding Genes with Cell Apoptosis and Diseases
Guomin Huang, Hongyan Li, Hong Zhang
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8879-8879
Open Access | Times Cited: 86
Early response evaluation by single cell signaling profiling in acute myeloid leukemia
Benedicte Sjo Tislevoll, Monica Hellesøy, Oda Helen Eck Fagerholt, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Acute myeloid leukemia (AML)‐derived mesenchymal stem cells induce chemoresistance and epithelial–mesenchymal transition‐like program in AML through IL‐6/JAK2/STAT3 signaling
Jianle Lu, QIAO-MEI DONG, Shuling Zhang, et al.
Cancer Science (2023) Vol. 114, Iss. 8, pp. 3287-3300
Open Access | Times Cited: 21
Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children
Svea Stratmann, Mattias Vesterlund, Husen M. Umer, et al.
Leukemia (2022) Vol. 37, Iss. 3, pp. 550-559
Open Access | Times Cited: 25
Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia
James C. Pino, Camilo Posso, Sunil K. Joshi, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 1, pp. 101359-101359
Open Access | Times Cited: 5
Toll-like Receptor 4, Osteoblasts and Leukemogenesis; the Lesson from Acute Myeloid Leukemia
Øystein Bruserud, Håkon Reikvam, Annette K. Brenner
Molecules (2022) Vol. 27, Iss. 3, pp. 735-735
Open Access | Times Cited: 19
A new hybrid algorithm for three-stage gene selection based on whale optimization
Junjian Liu, Chiwen Qu, Lupeng Zhang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Mitochondrial Ribosomal Proteins and Cancer
Huiyi Wu, Xiaowei Zhu, Huilin Zhou, et al.
Medicina (2025) Vol. 61, Iss. 1, pp. 96-96
Open Access
Establishment and Characterization of an Irinotecan-Resistant Human Colon Cancer Cell Line
Zhuo‐Xun Wu, Yuqi Yang, Leli Zeng, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 23
Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300
Mauro Rosales, George Perez, Ailyn C. Ramòn, et al.
Biomedicines (2021) Vol. 9, Iss. 7, pp. 766-766
Open Access | Times Cited: 18
Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice
Ankita Punetha, Deepak Kotiya
Proteomes (2023) Vol. 11, Iss. 1, pp. 2-2
Open Access | Times Cited: 7
Genes whose expressions in the primary lung squamous cell carcinoma are able to accurately predict the progression of metastasis through lymphatic system, inferred from a bioinformatics analyses
Khalil Khashei Varnamkhasti, Mehdi Moghanibashi, Sirous Naeimi
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Inhibition of NF-κB Signaling Alters Acute Myelogenous Leukemia Cell Transcriptomics
Håkon Reikvam
Cells (2020) Vol. 9, Iss. 7, pp. 1677-1677
Open Access | Times Cited: 19
Inferring kinase activity from phosphoproteomic data: Tool comparison and recent applications
Sander R. Piersma, Andrea Vallés‐Martí, Frank Rolfs, et al.
Mass Spectrometry Reviews (2022) Vol. 43, Iss. 4, pp. 725-751
Open Access | Times Cited: 12
Biological characteristics of aging in human acute myeloid leukemia cells: the possible importance of aldehyde dehydrogenase, the cytoskeleton and altered transcriptional regulation
Maria Hernandez-Valladares, Elise Aasebø, Frode S. Berven, et al.
Aging (2020) Vol. 12, Iss. 24, pp. 24734-24777
Open Access | Times Cited: 17
Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity
Sushma Bartaula-Brevik, Calum Leitch, Maria Hernandez-Valladares, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5546-5546
Open Access | Times Cited: 6
High Mitochondrial Protein Expression as a Potential Predictor of Relapse Risk in Acute Myeloid Leukemia Patients with the Monocytic FAB Subtypes M4 and M5
Frode Selheim, Elise Aasebø, Øystein Bruserud, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 8-8
Open Access | Times Cited: 6
The Constitutive Extracellular Protein Release by Acute Myeloid Leukemia Cells—A Proteomic Study of Patient Heterogeneity and Its Modulation by Mesenchymal Stromal Cells
Elise Aasebø, Annette K. Brenner, Even Birkeland, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1509-1509
Open Access | Times Cited: 14
Effects of the Autophagy-Inhibiting Agent Chloroquine on Acute Myeloid Leukemia Cells; Characterization of Patient Heterogeneity
Ida Sofie Grønningsæter, Håkon Reikvam, Elise Aasebø, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 8, pp. 779-779
Open Access | Times Cited: 14
Plant-derived extracts and metabolic modulation in leukemia: a promising approach to overcome treatment resistance
Cindy Arévalo, Nataly Cruz-Rodríguez, Sandra Quijano, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 5
The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives
Maria Hernandez-Valladares, Øystein Bruserud, Frode Selheim
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6830-6830
Open Access | Times Cited: 14
Proteomic-Based Analysis of Hypoxia- and Physioxia-Responsive Proteins and Pathways in Diffuse Large B-Cell Lymphoma
Kamila Duś‐Szachniewicz, Katarzyna Gdesz-Birula, Krzysztof Zduniak, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 2025-2025
Open Access | Times Cited: 12
Proteomic Studies of Primary Acute Myeloid Leukemia Cells Derived from Patients Before and during Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid and Valproic Acid
Maria Hernandez-Valladares, Rebecca Wangen, Elise Aasebø, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2143-2143
Open Access | Times Cited: 11
Anti-Th/To Antibodies in Scleroderma: Good Prognosis or Serious Concern?
Maria Możdżan, Andrzej Węgiel, Laura Biskup, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3022-3022
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top